Last reviewed: June 2018
Last updated: June  2018

Summary

Details

  • Initial counselling
  • Barrier methods
  • Barrier methods: the diaphragm and cervical cap
  • Barrier methods: the female condom
  • Barrier methods: the male condom
  • Barrier methods: spermicide
  • Behavioural methods
  • Behavioural methods: lactational amenorrhoea
  • Behavioural methods: periodic abstinence
  • Behavioural methods: withdrawal
  • Hormonal contraception
  • Combined hormonal contraceptives (oestrogen/progestogen)
  • Contraindications to oestrogen-containing contraceptives
  • Combined hormonal contraceptives: oestrogen/progestogen pills
  • Combined hormonal contraceptives: oestrogen/progestogen patch
  • Combined hormonal contraceptives: oestrogen/progestogen vaginal ring
  • Progestogen-only contraceptives
  • Progestogen-only contraceptives: progestogen-only pill
  • Progestogen-only contraceptives: progestogen implant
  • Progestogen-only contraceptives: progestogen injection
  • Non-contraceptive benefits of hormonal contraceptives
  • Intrauterine devices (IUDs)
  • Intrauterine devices: copper IUD
  • Intrauterine devices: progestogen IUD
  • Sterilisation
  • Sterilisation: female sterilisation
  • Sterilisation: male sterilisation
  • Emergency contraception
  • Emergency contraception: progestogen-only emergency contraception
  • Emergency contraception: ulipristal
  • Emergency contraception: copper IUD
  • Emergency contraception: oestrogen/progestogen emergency contraception

Contributors

Authors VIEW ALL

Associate Professor

Johns Hopkins University

Baltimore

MD

Disclosures

AB has received research funding from Bayer and NICHD through Johns Hopkins University.

Assistant Clinical Professor

Mount Sinai School of Medicine

New York

NY

Disclosures

RL declares that she has no competing interests.

Peer reviewers VIEW ALL

Associate Professor of Family and Community Medicine

Associate Professor of Obstetrics and Gynecology

Family Medicine Department

University of New Mexico

Albuquerque

NM

Disclosures

LL declares that he has no competing interests.

Director

TEACH Program

Assistant Clinical Professor

UCSF and UCD

San Francisco

CA

Disclosures

SG has served as an Implanon training specialist for Organon Inc.

Consultant in Sexual and Reproductive Health

Lewisham Primary Care Trust

Waldron Health Centre

London

UK

Disclosures

LB was a member of the group that produced the 2006 Faculty of Sexual and Reproductive Health guidance on the management of women with vaginal discharge presenting in non-GU setting.

Use of this content is subject to our disclaimer